🔎 Trials Near Me

Akèy › Kansè vejik › Wisconsin › Milwaukee

Etid klinik pou Kansè vejik nan Milwaukee, WI

11 etid pou Kansè vejik ap chèche patisipan nan sit nan ak bò kote Milwaukee (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • ak 9 plis
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Ap rekriteFaz 2
  • Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa, Wauwatosa · 5 mi lwen
  • Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield, Brookfield · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06770582

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Ap rekriteFaz 2
  • Ascension Columbia Saint Mary's Hospital-Milwaukee Campus, Milwaukee
  • Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa, Wauwatosa · 5 mi lwen
  • Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield, Brookfield · 10 mi lwen
  • ak 2 plis
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07061964

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • ak 7 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

The Vanguard Study: Testing a New Way to Screen for Cancer

Ap rekriteVolontè an sante akeyi
  • Zablocki Veterans Administration Medical Center, Milwaukee
Laj 45 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06995898

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

Ap rekrite
  • Froedtert Hospital, Milwaukee
Laj 65 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07227077

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Ap rekriteFaz 1/2
  • Froedtert Hospital / Medical College of Wisconsin, Milwaukee
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Ap rekriteFaz 3
  • Research Site, Milwaukee
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07720284

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Ap rekriteFaz 2
  • Froedtert Hospital/Medical College of Wisconsin, Milwaukee
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT04879329

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Ap rekriteEtid obsèvasyon
  • Medical College of Wisconsin, Milwaukee
Laj 18 ak plis · Tout sèks · Mizajou Mar 5, 2026 · NCT04075305

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Milwaukee
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè vejik nan lòt vil

Lòt etid nan Milwaukee

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.